Introduction {#S0001}
============

Multimodal imaging nanoplatforms have evoked considerable interest to circumvent the limitations of single imaging modes and incorporate the advantages of different imaging modality.[@CIT0001],[@CIT0002] A number of imaging techniques are introduced to these platforms for clinical diagnosis.[@CIT0003],[@CIT0004] Among the diverse diagnostic techniques, X-ray computed tomography (CT) displays a high degree of spatial resolution of the hard tissues, and magnetic resonance imaging (MRI) is a powerful noninvasive modality with excellent soft-tissues resolution.[@CIT0005],[@CIT0006] MRI and CT are suitable for anatomical reconstruction but have poor sensitivity and lack of molecular details.[@CIT0007],[@CIT0008] Near-infrared fluorescence (NIRF) imaging is suitable for multiscale imaging from the cellular level to whole-body animals.[@CIT0008],[@CIT0009] To achieve multifunction with MR, CT, and NIRF imaging, combining different imaging contrast agents into a macromolecule or encapsulation of them into a special nanostructure (e.g., hollow nanosphere or mesoporous nanoparticle) has become a main strategy.[@CIT0010]--[@CIT0013] However, the magnetic, X-ray attenuation, and fluorescent properties usually originate from different molecules (or moieties),[@CIT0013] and the combination of all of these functions into one nanoplatform usually not only requires a complicated synthetic procedure but lead to heterogeneous nanostructure.[@CIT0014] Moreover, the introduction of an additional function is often accompanied by a decrease in the original function.[@CIT0014] Therefore, it is necessary to explore effective synthetic strategies to fabricate excellent multifunction nanomaterials for multimodal bioimaging.

Gold nanoclusters (AuNCs) are intensely investigated as imaging contrast agents, owing to intensive fluorescence, extraordinary photostability, easy synthesis, and excellent biocompatibility.[@CIT0015]--[@CIT0018] Based on strong quantum confinement effect (SQCE) related to the size of clusters, AuNCs with different sizes may exhibit unique optical properties which extend from the red-spectral region to the biologically important near-infrared (NIR) window.[@CIT0019],[@CIT0020] Recently, the composite nanomaterials with AuNCs have been extensively explored in multimodal imaging systems, such as fluorescence/CT, fluorescence/Magnetic resonance imaging (MRI), fluorescence/positron emission tomography (PET).[@CIT0021],[@CIT0022] However, complicated synthetic procedure and interactions between different imaging components lead to the decrease and instability of the fluorescence characteristics of AuNCs. Fortunately, gold atoms with high atomic number and electron density possess high X-ray attenuation coefficient.[@CIT0023],[@CIT0024] In our previous study, a sub-nanometer ultrasmall AuNCs with 15 gold atoms (Au~15~NCs) may have access to both alluring optical characteristics and remarkable X-ray attenuation properties.[@CIT0025] Therefore, Au~15~NCs have great potential to be used as multimodal imaging platform to achieve both NIRF and CT imaging ability.

In this study, a novel kind of biocompatible and high-performing trimodal contrast agent (Au~15~NCs-DTPAA-Gd) has been elaborately designed through covalently conjugating gadolinium-Diethylenetriamine-pentaacetic acid dianhydride (DTPAA-Gd) to Au~15~NCs. Only by coupling Au~15~NCs with gadolinium chelate, the obtained Au~15~NCs-DTPAA-Gd exhibit dramatically promoted longitudinal relaxivity, near-infrared fluorescence signal and X-ray attenuation properties. It is worth noting that imaging components promote each other, which addresses the limitations of interference between imaging elements of conventional multimodal platforms. The in vivo imaging ability was validated on mice through MR and CT imaging, where Au~15~NCs-DTPAA-Gd produced robust and prolonged contrast enhancement. The in vivo fluorescent imaging was validated on nude mice, where the red light produced by Au~15~NCs-DTPAA-Gd under 485 nm excitation light can effectively penetrate the tissue and be observed by the human eye. The pharmacokinetics and biodistribution studies display appropriately decelerated plasma decay and renal excretion, which would be of great significance in accurate clinical diagnosis. The nanometer platform enables the perfect integration of each component and maximizes the imaging capacity of each component, which has great potential for medical imaging. To the best of our knowledge, this is the first report associated with the synthesis of DTPAA-Gd-functionalized Au~15~NCs for NIRF/CT/MR trimodal imaging applications.

Materials and Methods {#S0002}
=====================

Materials {#S0002-S2001}
---------

All chemicals of analytical grade were used without further purification. Chloroauric acid (HAuCl~4~·4H~2~O) was purchased from Chemart (Tianjin, China). Reduced glutathione (rGSH, 98%) was obtained from Solarbio (Beijing, China). Diethylenetriamine-pentaacetic acid dianhydride (DTPAA, 95%) was purchased from Alfa Aesar (Shanghai, China). Gadolinium (Ⅲ) chloride (GdCl~3~·6H~2~O), Dimethyl sulfoxide (DMSO, \>99%), and Sodium acetate anhydrous (CH~3~COONa) were purchased from Sigma-Aldrich (St. Louis, USA). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was purchased from Merck (Germany). The other chemicals were purchased from Sigma-Aldrich (St. Louis, USA). Deionized water used throughout the experiments was acquired from Mili-Q water purification system after its resistivity reached 18.2 MΩ CM.

Human renal epithelial cell line (293T cell line) and human hepatocellular carcinoma cell line (HepG2 cell line) were acquired from Molecular Imaging Lab of Tianjin Medical University (Tianjin, China). The use of these cell lines had Molecular Imaging Lab of Tianjin Medical University review board approval. The female BALB/c mice and BALB/c athymic nude mice were obtained from Beijing Vital River Laboratory Animal Technology Co., Ltd (Beijing, China).

Synthesis of Au~15~NCs-DTPAA-Gd {#S0002-S2002}
-------------------------------

First, ultrasmall gold nanoclusters with 15 gold atoms (Au~15~NCs) were prepared according to our previous report.[@CIT0025] The freshly prepared aqueous solutions of HAuCl~4~ (24 mM, 4.2 mL) were mixed into a 50-mL glass flask containing 43.5 mL of deionized water, and then 12 mg rGSH was added into HAuCl~4~ solutions (rGSH/Au^3+^ 2:1) under vigorously stirring in water bath until a colorless and transparent solution was formed. Subsequently, PH value of the above solution was adjusted to 9 with 1 M NaOH solution. Then, the above solution was heated to 70°C and kept gently stirring for 24 h. After reaction finished, the resultant Au~15~NCs\@GSH were precipitated by ethanol via centrifugation, washed several cycles and finally re-dispersed in PBS for next modification.

Then, the synthesis of Au~15~NCs-DTPAA-Gd followed a typical amide reaction pattern with a slight modification. Firstly 24 mg of DTPAA dissolved in DMSO was added into 600 μL of the above-prepared Au~15~NCs\@GSH solution under gently stirred, and NaOH solution was used to adjust the pH to 8.5. After 2 h of stirring, 12 mg of GdCl~3~·6H~2~O dissolved in CH~3~COONa (0.1M, 125 μL) was added dropwise into the above mixture under gently stirring, and the pH was regulated to 7 using 1 M NaHCO~3~ solution. After stirring at 25°C for 24 h, the obtained Au~15~NCs-DTPAA-Gd were washed with PBS by ultrafiltration centrifugation several times to extract excess Gd^3+^. The final products were redispersed in 250 μL PBS and stored at 4°C for further use.

Characterization {#S0002-S2003}
----------------

Transmission Electron Microscopy (TEM) and Energy-dispersive X-ray Spectroscopy (EDX) element mapping were obtained using Jeol's Jem-2100F operating at 200 kV. Hydrodynamic size of nanohybrids dispersed in water was recorded by a Malvern Zeta Sizer 3000 HS (Malvern, UK). The surface potential charge was determined with the same instrument equipped with an AQ-827 electrode. The fluorescence spectra were characterized by 960PC spectrofluorometer (INESA, Shanghai, China). The absorption spectra were measured UV-visible-NIR UV1800 spectrophotometry (SHIMADZU, Suzhou, China). The fluorescence quantum yield of Au~15~NCs and Au~15~NCs-DTPAA-Gd was determined by relative measurement with rhodamine B as fluorescence standard. The quantities of Au and Gd in the Au~15~NCs-DTPAA-Gd nanohybrids were determined by Inductively Coupled Plasma-Atomic Emission Mass Spectrometry (ICP-AES) analysis (Optima 5300 DV, Perkin Elmer, MA).

In vitro CT/NIRF/MR Imaging {#S0002-S2004}
---------------------------

The in vitro CT imaging of Au~15~NCs, Au~15~NCs-DTPAA-Gd and Omnipaque was acquired using Light Speed VCT system (General Electric Company, America) with imaging parameters: 120 keV, 80 mA, and a slice thickness of 0.625 mm. Evaluation of the X-ray attenuation intensity was carried out by loading the digital CT images in a standard display program (GE Advantage Workstation AW4.4) and then selecting a uniform round region of interest on the resulting CT image of each sample. Contrast enhancement (Hounsfield units, HU) was determined for each concentration of Au~15~NCs, Au~15~NCs-DTPAA-Gd and Omnipaque. The in vitro fluorescence imaging was performed under UV light (365 nm) and Caliper IVIS Lumina II imaging system and Berthold LB983 live animal imaging system (Berthold Technologies, Germany, ex = 485 nm; em = 700 nm). The in vitro MR imaging of Au~15~NCs-DTPAA-Gd and Magnevist was obtained using 3.0 T MR scanner with CUBE T~1~ sequence: Freq. FOV, 10.0 mm^2^; phase FOV, 1.00 mm^2^; slice thickness, 1.0 mm; spacing, 0.2mm; TR, 400.0 ms; TE, 9 ms; matrix, 196 × 196; NEX, 3. The longitudinal (T~1~) and transverse (T~2~) relaxation times of Au~15~NCs-DTPAA-Gd at different Gd^3+^ concentrations were determined using 3.0 T MR scanner (Discovery 750, General Electric Company, America) with the pulse sequence time parameters: Freq. FOV, 10.0 mm^2^; phase FOV, 1.00 mm^2^; echo time (TE), 160 ms; repetition time (TR), 600 ms; slice thickness, 1 mm; spacing, 1.0 mm. The linear fitting of inverse T~1~ and T~2~ relaxation time (1/T~1~ and 1/T~2~) as a function of Gd concentration (mM) were taken to calculate the T~1~ (r~1~) and T~2~ (r~2~) relaxivity. The slope of the fitting line is the relaxivity.

Stability Analysis {#S0002-S2005}
------------------

The colloidal stability of the Au~15~NCs-DTPAA-Gd was estimated by UV-visible-NIR UV1800 spectrophotometry, 960PC spectrofluorometer and 3.0 T MR scanner. Au~15~NCs-DTPAA-Gd nanohybrids were incubated in phosphate-buffered saline (PBS) for a period of time (0 d, 7 d, 15 d, 30 d) at room temperature. For MRI, the incubated Au~15~NCs-DTPAA-Gd nanohybrids were precipitated by ethanol via centrifugation several cycles to remove free Gd^3+^ and finally re-dispersed in the above solutions for MRI.

In vitro Cytotoxicity Studies {#S0002-S2006}
-----------------------------

293T cells and HepG2 cells were planted into 96-well plates at a density of 1×10^4^ cells. For MTT assay, cells in logarithmic growth were incubated with various concentrations of Au~15~NCs-DTPAA-Gd for 24 h, and the cells treated with PBS as control. Thereafter, 20 μL of MTT solution (5 mg/mL) was added into each well and incubated for 4 h at 37°C, followed by removal of the medium and addition of 200 μL DMSO to dissolve the formed purple formazan crystals. Next, the plates were shaken for 15 min. The absorbance (OD) at 490 nm was recorded by microplate reader (Thermo Scientific, USA) to measure the proliferative capacity of each group. Five wells of each concentration were set up to obtain the average value. The relative viability ratios of treated groups were calculated by the percentage of OD~490~ value of the treated cells over the untreated cells.

Cell Uptake {#S0002-S2007}
-----------

Intracellular uptake of Au~15~NCs-DTPAA-Gd was measured in HepG2 cells and 293T cells. Cells were grown on 14 mm glass coverslips and allowed to adhere for 24 h. After co-incubation with 10 mg/mL Au~15~NCs-DTPAA-Gd for different times, the cells were washed with PBS sufficiently to remove excess nanoclusters and fixed with 4% paraformaldehyde, and nuclei of the cells were stained with 4ʹ-6-diamidino-2-phenylindole (DAPI, 1 mg/mL in PBS, invitrogen). DAPI emission was recorded between 440 and 470 nm, Au~15~NCs-DTPAA-Gd emission images were obtained using a 630 nm longpass filter. Confocal fluorescence imaging studies were performed with confocal laser scanning microscope (Olympus FV10i, Tokyo, Japan).

In vivo CT/NIRF/MR Imaging {#S0002-S2008}
--------------------------

All animal experiments were carefully handled under the guidelines approved and supervised by the ethics committee of Institute of Radiation Medicine, Chinese Academy of Medical Sciences (Approval No.: IRM-DWLL-2019055). For CT imaging, a PBS solution of Au~15~NCs-DTPAA-Gd (0.1 mol/L Au, 100 μL) was intravenously injected into BALB/c mice. The mice were placed in the LightSpeed VCT system and scanned at an interval of 5 mins under 120 kV, 80 mA with the slice thickness was 0.625 mm. For NIRF imaging, the nude mice were intravenously injected with Au~15~NCs-DTPAA-Gd nanohybrids (0.1 mol/L Au, 100 μL). The fluorescence signals are collected by a Berthold LB983 live animal imaging system (λex = 485 nm/λem = 700 nm) at different time intervals. The T~1~-weighted MR imaging for mice was performed by 3.0 T MR scanner before and after the injection of Au~15~NCs-DTPAA-Gd nanohybrids solution (at a dosage of 0.1 mmol Gd/kg, 100 μL). T~1~ FSE sequence was applied with the parameters: TR, 800 ms; TE, Min Full; slice thickness = 1.0 mm, spacing = 0.2 mm, matrix = 256 × 256. All experiments were repeated three times.

In vivo Pharmacokinetics and Biodistribution Analysis {#S0002-S2009}
-----------------------------------------------------

For pharmacokinetic study, BALB/c mice were administered 150 μL of Au~15~NCs-DTPAA-Gd via tail vein. Blood samples were collected from eye socket at indicated time points (5 min, 10 min, 15 min, 20 min, 30 min, 1 h, 2 h, 4 h, 6 h), followed by weighing and dissolution in digestive chloroazotic acid (V~HCl~/V~HNO3~ = 1/3) to quantify the amount of Au and Gd via ICP-MS. Two-compartment pharmacokinetic model analysis of the data was performed with originpro software, and the pharmacokinetic parameters (e.g. elimination half-life, T~1/2~) were calculated from the Gd contents in blood.

For biodistribution analysis, mice were sacrificed after 10 mins, 30 mins, 2 hrs and 24 hrs post-injection, and major organs (heart, liver, spleen, lung, kidney) were extracted and digested in aqua regia (6 mL) overnight. Solutions were then diluted to 10 mL with deionized water. Finally, Au and Gd contents in each organ were analyzed by ICP-MS. Results were expressed as the percentage of the injected dose g^−1^ (%ID/g). All experiments were repeated three times.

In vivo Biocompatibility Evaluation {#S0002-S2010}
-----------------------------------

Biocompatibility of Au~15~NCs-DTPAA-Gd in vivo was evaluated by tissue Hematoxylin and eosin (H&E) staining. At 24 h and 2 weeks after injection with Au~15~NCs-DTPAA-Gd, the mice were sacrificed under anesthetic conditions. Tissues of interest (heart, liver, spleen, lung, and kidney) were excised and preserved in a 10% formalin solution for 2 weeks. Then, the formalin fixed tissues from each organ were embedded into paraffin and sectioned into 4 mm thickness. Each histological section was documented by a dissecting microscope. The tissues were sectioned into 4-mm thickness. Each histological section was documented by a dissecting microscope. The histological assessment was done with the help of the pathologist. Six mice injected with Au~15~NCs-DTPAA-Gd served as experimental group. We chose three tissue slices from each organ to perform H&E staining experiments.

Results and Discussion {#S0003}
======================

Synthesis and Characterization of Au~15~NCs-DTPAA-Gd {#S0003-S2001}
----------------------------------------------------

In our study, the Au~15~NCs were synthesized by a one-step reduction method according to our previous optimized protocol.[@CIT0026] Fifteen gold atoms form stable Au~15~NCs with glutathione via a strong thiolate-Au interaction. Au~15~NCs-DTPAA-Gd were synthesized via a classical amide reaction ([Scheme 1](#SCH0001)). As determined by TEM ([Figure 1A](#F0001){ref-type="fig"}), the monodispersed spherical Au~15~NCs have a mean diameter of less than 1.0 nm. After conjugation with DTPAA-Gd, the well-dispersed Au~15~NCs-DTPAA-Gd nanohybrids remain a spherical shape and an average size of approximately 1.0 ± 0.4 nm with no significant change, as shown in [Figure 1B](#F0001){ref-type="fig"}. Elemental analysis by the corresponding EDS spectrum confirmed the composition and atomic distribution of the synthetic nanohybrids. The spectra and mapping of Au~15~NCs-DTPAA-Gd exhibit the presence of Au, Gd, C, and O ([[Figure S1](https://www.dovepress.com/get_supplementary_file.php?f=227169.docx)]{.ul}), with different colors consistent with the chemical composition in the Au~15~NCs-DTPAA-Gd nanohybrids. ICP-MS results show that the ratio between Gd and Au of Au~15~NCs-DTPAA-Gd is about 1 to 1, which confirms that about fifteen Gd-DTPAA can conjugate with glutathione from the surface of the Au cluster via an amide bond. Due to further increasing the Gd^3+^ relative to the Au~15~NCs, the MRI capability of the synthesized Au~15~NCs-DTPAA-Gd is not significantly improved, so we chose this ratio. For better application in vivo, the hydrodynamic diameter of Au~15~Ns and Au~15~NCs-DTPAA-Gd nanohybrids was measured by dynamic light scattering (DLS). The hydrodynamic diameter of Au~15~NCs is 1.0 ± 0.3 nm ([Figure 1B](#F0001){ref-type="fig"}) and that of Au~15~NCs-DTPAA-Gd is 2.5 ± 0.4 nm ([Figure 1C](#F0001){ref-type="fig"}). The hydrodynamic diameter is slightly larger than that observed with TEM, which results from the hydration of rGSH and DTPAA-Gd in water. [Figure 1E](#F0001){ref-type="fig"} displays the UV-visible-NIR absorption spectra and emission spectra of Au~15~NCs and Au~15~NCs-DTPAA-Gd. A typical absorption spectrum of Au~15~NCs with distinct peaks at 370/410 nm is plotted in black solid line which is consistent with the reported literature.[@CIT0027] Unlike the most popular and well-known spherical, large gold nanoparticles (AuNPs), AuNCs do not exhibit surface plasmon resonance (SPR) absorption in the visible region.[@CIT0016],[@CIT0028],[@CIT0029] It is apparent that the absorption band of Au~15~NCs-DTPAA-Gd is similar to that of Au~15~NCs. It can be speculated that the introduction of DTPAA-Gd has no obvious effect on the Au~15~NCs, and no AuNPs are formed to stimulate surface plasmon resonance under these conditions. By fluorescence spectrophotometry, the emission spectra of Au~15~NCs-DTPAA-Gd and Au~15~NCs are similar with range of 550--800 nm peaking at 680 nm, suggesting their deep tissue penetration ability. The quantum yields of Au~15~NCs and Au~15~NCs-DTPAA-Gd were measured to be 7.8% and 7.6% at λ~ex~ 470 nm, respectively.[@CIT0015],[@CIT0029],[@CIT0030] The zeta potentials of Au~15~NCs and Au~15~NCs-DTPAA-Gd are about −5 mV and −24 mV, respectively ([Figure 1F](#F0001){ref-type="fig"}). The carboxylic groups of rGSH and DTPAA on the surface of the Au~15~NCs may cause Au~15~NCs and Au~15~NCs-DTPAA-Gd to be negatively charged. These results indicate Gd functionalization of Au~15~NCs by amide reaction is feasible.Figure 1Characterization of the nanohybrids. TEM images of (**A**) Au~15~NCs and (**C**) Au~15~NCs-DTPAA-Gd; Size distribution histograms of (**B**) Au~15~NCs and (**D**) Au~15~NCs-DTPAA-Gd; (**E**) UV-visible-NIR absorbance spectra and fluorescence emission spectra of Au~15~NCs and Au~15~NCs-DTPAA-Gd in PBS. (**F**) Zeta potentials of Au~15~NCs and Au~15~NCs-DTPAA-Gd.Scheme 1Schematic illustration of the synthetic procedure and multimodal imaging for Au~15~NCs-DTPAA-Gd nanohybrids.

In vitro CT/NIRF/MR Imaging {#S0003-S2002}
---------------------------

The synthesized Au~15~NCs-DTPAA-Gd possess excellent three model imaging properties. Owing to the higher atomic numbers and electron densities (79, 19.32 g/cm[@CIT0003]) of gold element than that of iodine (53, 4.93 g/cm^3^), the attenuation intensity of Au~15~NCs-DTPAA-Gd was thus measured to assess the feasibility of their application as CT contrast agent. The CT images of Au~15~NCs-DTPAA-Gd nanohybrids at various concentration levels in [Figure 2A](#F0002){ref-type="fig"} indicate an obvious increase of the brightness with the increase of the hybrid concentration. Quantitative calculation ([Figure 2B](#F0002){ref-type="fig"}) confirms a linear relationship between the attenuation intensity and the content of Au in the nanohybrids. What is particularly remarkable is that there is almost twofold amplified attenuation intensity of Au~15~NCs-DTPAA-Gd compared with Omnipaque at equivalent concentration (I or Au). It is additionally demonstrated that the attenuation intensity of Au~15~NCs-DTPAA-Gd is higher than that of Au~15~NCs at the same Au concentrations. The phenomenon may be attributed to the existence of Gd ions possessing the relatively high atomic number and electron densities (64, 7.895 g/cm^3^),[@CIT0031] which results in synergistic enhancement of CT imaging capability. These observations well illustrate that the prepared Au~15~NCs-DTPAA-Gd provide a promising contrast agent for CT imaging.Figure 2(**A**) In vitro CT imaging of Omnipaque, Au~15~NCs and Au~15~NCs-DTPAA-Gd. (**B**) The corresponding X-ray attenuation intensity plot at various concentrations (0, 0.00625, 0.0125, 0.025, 0.05 and 0.1 mol L^−1^).

The photographs in [Figure 3A](#F0003){ref-type="fig"} and [B](#F0003){ref-type="fig"} display that the brown solution of Au~15~NCs and Au~15~NCs-DTPAA-Gd (room light) emitted similar intense-red fluorescence under UV light (365 nm). As NIRF imaging agents, Au~15~NCs show strong quantum confinement effects and molecule-like properties while avoiding the photobleaching problems of conventional organic dyes. As shown in [Figure 3C](#F0003){ref-type="fig"}, both Au~15~NCs and Au~15~NCs-DTPAA-Gd nanohybrids exhibit similarly obvious enhancement of the NIRF signal with an increase of Au concentration. Moreover, the introduction of an additional functional DTPAA-Gd makes no effect on fluorescence property of Au~15~NCs. DTPAA is directly connected to glutathione on the surface of Au~15~NCs via an amide bond, which does not cause glutathione to detach significantly from the surface of gold. Therefore, the surface function of Au~15~NCs is not affected greatly. Meanwhile, the introduction of DTPAA-Gd did not significantly increase the size of Au~15~NCs. These factors may lead to no significant change in the fluorescence of Au~15~NCs-DTPAA-Gd compared with that of Au~15~NCs.Figure 3Photographs of (**A**) Au~15~NCs and (**B**) Au~15~NCs-DTPAA-Gd under irradiation by natural light (left) and UV light (365 nm, right). (**C**) In vitro NIFR imaging of Au~15~NCs and Au~15~NCs-DTPAA-Gd with different concentrations.

It is known that Gd^3+^ is able to induce the longitudinal relaxation of water protons, shorten the longitudinal relaxation time (T~1~) and enhance MR imaging effect.[@CIT0032] In the present case, T~1~ and T~2~ values of Au~15~NCs-DTPAA-Gd nanohybrids at various concentrations in aqueous medium were measured to estimate the longitudinal (r~1~) and transverse (r~2~) relaxivity. A dose-dependent brightening effect is observed in T~1~-weighted MR imaging ([Figure 4A](#F0004){ref-type="fig"}), r~1~ and r~2~ were calculated to be 8.5 and 9.6 mM^−1^ s^−1^ (with an r~2~/r~1~ ratio of 1.13) ([Figure 4C](#F0004){ref-type="fig"}), respectively. Importantly, MR signal intensity of Au~15~NCs-DTPAA-Gd is much stronger than that of Magnevist ([Figure 4A](#F0004){ref-type="fig"} and [B](#F0004){ref-type="fig"}), and the r~1~ of Au~15~NCs-DTPAA-Gd exhibits about two times than that of Magnevist (3.97 mM^−1^ S^−1^). Due to fifteen Gd-chelates formed on the surface of Au~15~NCs, it may be speculated that possible explanations for relatively higher r~1~ value and MR signal of Au~15~NCs-DTPAA-Gd compared to Magnevist include: (i) an increase in rotational correlation time by virtue of the attachment of the metal chelate to macromolecules, (ii) an increase in the number of outer sphere-coordinated water molecules entrapped by the Au~15~NCs\@GSH, and (ⅲ) the cooperative induction effect by the surface gadolinium in Au~15~NCs-DTPAA-Gd.[@CIT0033],[@CIT0034] This indicates a promising potential for utilizing Au~15~NCs-DTPAA-Gd nanohybrids as a superior T~1~-weighted MR imaging contrast agent.Figure 4(**A**) In vitro T~1~-weighted MR images of Magnevist and Au~15~NCs-DTPAA-Gd. (**B**) The corresponding MR signal intensity. (**C**) T~1~ and T~2~ relaxivity plots as a function of Gd concentration (0, 0.025, 0.05, 0.1 and 0.2 mmol L^−1^), the corresponding slopes give rise to r~1~ and r~2~ values of Au~15~NCs-DTPAA-Gd.

Stability Analysis and Cytotoxicity {#S0003-S2003}
-----------------------------------

For further biomedical applications of Au~15~NCs-DTPAA-Gd, it is necessary to check stability in bio-fluids. The colloidal stability of Au~15~NCs-DTPAA-Gd dissolved in PBS was monitored constantly at different storage time points. In vitro MRI Au~15~NCs-DTPAA-Gd ([Figure 5A](#F0005){ref-type="fig"}) shows no significant decrease in MRI signals over time, which confirms that the chelated Gd^3+^ of Au~15~NCs-DTPAA-Gd is excellently stable. [[Figure S2](https://www.dovepress.com/get_supplementary_file.php?f=227169.docx)]{.ul} shows that no significant changes in the absorption peak position or fluorescence intense happened at different time points. Over this period, there is no precipitation in the solution, and the color of the solution does not change significantly ([[Figure S2](https://www.dovepress.com/get_supplementary_file.php?f=227169.docx)]{.ul} inset), which demonstrates favorable water dispersibility of Au~15~NCs-DTPAA-Gd nanohybrids. These results confirm that the physicochemical properties of Au~15~NCs in Au~15~NCs-DTPAA-Gd nanohybrids are quite stable.Figure 5(**A**) The MR images and signal intensity of Au~15~NCs-DTPAA-Gd incubated in PBS for different time (0 d, 7 d, 15 d, 30 d) at room temperature. The data is represented as mean ± standard deviation, n=3/group. (**B**) Viabilities of 293T and HepG2 cells treated with different concentrations of Au~15~NCs-DTPAA-Gd nanohybrids for 24 h.

The in vitro cytotoxicity of Au~15~NCs-DTPAA-Gd against 293T and HepG2 cells was investigated via MTT assays. As shown in [Figure 5B](#F0005){ref-type="fig"}, more than 90% of the 293T and HepG2 cells all stay alive even when the concentration of Au~15~NCs-DTPAA-Gd reaches up to 1 mg/mL concentration. This clearly demonstrates that Au~15~NCs-DTPAA-Gd possess a favorable biocompatibility.

Cell Uptake Studies {#S0003-S2004}
-------------------

In this work, we want to initially explore the potential of Au~15~NCs-DTPAA-Gd as multimodal imaging probe of tumors, so the affinity of Au~15~NCs-DTPAA-Gd to tumor cells is of vital significance. The in vitro intake of Au~15~NCs-DTPAA-Gd by HepG2 and 293T cells was monitored with confocal fluorescence microscopy. As illustrated in [Figure 6](#F0006){ref-type="fig"}, when HepG2 cells were incubated with Au~15~NCs-DTPAA-Gd for 24 h, obvious-red fluorescence was observed and mainly existed around the nucleus at 405 nm excitation. Compared with HepG2 cells, 293T cells incubated with Au~15~NCs-DTPAA-Gd for 24 h did not exhibit significant fluorescence. These results illustrated Au~15~NCs-DTPAA-Gd may efficiently enter cytoplasm through endocytosis of active cancer cells.Figure 6The Confocal microscopy images of HepG2 and 293T cells incubated for 24 h with Au~15~NCs-DTPAA-Gd nanohybrids. Scale bar: 50 μm.

In vivo CT/NIRF/MR Imaging {#S0003-S2005}
--------------------------

The feasibility of Au~15~NCs-DTPAA-Gd as in vivo CT/NIRF/MR trimodal imaging agent was exploited on BALB/c mice. Firstly, the accumulation of Au~15~NCs-DTPAA-Gd in liver makes this region brighter in CT image after 5-min injection with respect to that observed without administration ([Figure 7A](#F0007){ref-type="fig"}a). The X-ray attenuation intensities in the liver region before and after Au~15~NCs-DTPAA-Gd administration were quantitatively calculated to be 64.7 ± 2.2 HU and 120.5 ± 3.4 HU, respectively. After 10-min injection, both kidneys become clearer and brighter than those observed without administration ([Figure 7A](#F0007){ref-type="fig"}b). In the following, NIRF imaging was performed by intravenous administration of Au~15~NCs-DTPAA-Gd. [Figure 7B](#F0007){ref-type="fig"} illustrates an obvious enhancement on the fluorescence signal in mice liver after a 5-min injection. It is seen that obvious signal is observed in bladder at 20-min post-injection, indicating that Au~15~NCs-DTPAA-Gd is mainly eliminated via urinary route. Subsequently, T~1~-weighted MR images of mice were acquired before and after administering medication. It is seen that the liver is brightened after a 5-min injection ([Figure 7C](#F0007){ref-type="fig"}c). In addition, T~1~-weighted MRI and MIP images of cardiovascular ([Figure 7C](#F0007){ref-type="fig"}c-d) after a 5-min injection were acquired. It is clearly observed that the cardiovascular function of the mice was significantly enhanced after injection. As shown in [Figure 7C](#F0007){ref-type="fig"}e, both kidneys are brightened after 10-min injection, which are consistent with that observed in CT. [Figure 7C](#F0007){ref-type="fig"}f shows that the bilateral renal pelvis is clear after 30-min injection. These observations suggest that the present Au~15~NCs-DTPAA-Gd platform exhibits favorable CT/NIRF/MR imaging capability in vivo.Figure 7In vivo (**A**) CT, (**B**) NIRF, and (**C**) T~1~-weighted MR imagingat different time intervals after intravenous injection of Au~15~NCs-DTPAA-Gd. CT imaging of the liver (**A**a) and kidneys (**A**b) before and after injection. T1-weighted MR (**C**a) and Maximum Intensity Projection (MIP) imaging (**C**b) before injection. T1-weighted MR (**C**c) and MIP (**C**d) imaging of cardiovascular after 5-min injection. T1-weighted MR imaging after 10-min and 30-min injection (**C**e-f).

In vivo Pharmacokinetics and Biodistribution Analysis {#S0003-S2006}
-----------------------------------------------------

To explore the pharmacokinetic and biodistribution of Au~15~NCs-DTPAA-Gd, element gold and Gd of blood and organs were proceeded after injection of Au~15~NCs-DTPAA-Gd. As seen in [[Figure S3A](https://www.dovepress.com/get_supplementary_file.php?f=227169.docx)]{.ul}, blood circulation behavior of Au~15~NCs-DTPAA-Gd is excellently conformed to two-compartment pharmacokinetics with blood elimination half-life (T~1/2~) of 24.9 ± 0.5 min. The ideally longer elimination half-life compared to Omnipaque and Magnevist might aid to imaging and minimizing organ damage. The biodistribution of Au~15~NCs-DTPAA-Gd based on ICP-MS ([[Figure S3B](https://www.dovepress.com/get_supplementary_file.php?f=227169.docx)]{.ul}) reveals that the elemental distribution of Au in the different organs is similar to that of Gd^3+^ ions in the mice post-injection of Au~15~NCs-DTPAA-Gd, further suggesting that Au~15~NCs-DTPAA-Gd are formed by the assimilation of Au~15~NCs with Gd^3+^ ions rather than as a result of a mixture of Au~15~NCs and Gd^3+^ ions. The ICP-MS results also indicate a fast urine elimination of Au~15~NCs-DTPAA-Gd, as the Au~15~NCs-DTPAA-Gd significantly accumulate in the kidney post-injection and are almost cleared from the kidney with a prolonged circulation time of 2 hrs. Moreover, a small amount of Au and Gd remain in heart, liver, spleen, and lung post-injection, suggesting a low uptake of Au~15~NCs-DTPAA-Gd by Reticulo-Endothelial System (RES) tissues and that Au~15~NCs-DTPAA-Gd are not significantly retained in the lung. These observations indicate that Au~15~NCs-DTPAA-Gd are safe for in vivo biomedical imaging applications.

In vivo Biocompatibility Evaluation {#S0003-S2007}
-----------------------------------

The in vivo toxicity of Au~15~NCs-DTPAA-Gd was evaluated by monitoring the pathological changes of several major organs of all mice using H&E staining sections. As shown in [Figure 8](#F0008){ref-type="fig"}, compared to the control mice treated with PBS, the injection of the Au~15~NCs-DTPAA-Gd seems not to induce any noticeable changes in the morphology and other lesions (such as necrosis and inflammatory) of the organ sections from all mice. These results imply that Au~15~NCs-DTPAA-Gd possess good biocompatibility for applications.Figure 8In vivo biocompatibility evaluation of Au~15~NCs-DTPAA-Gd. Histological analyses of main organs (heart, liver, spleen, lung and kidney) stained with hematoxylin and eosin (H&E) from the mice injected with Au~15~NCs-DTPAA-Gd.

Conclusions {#S0004}
===========

In this work, a facile approach is developed for the configuration of multimodal imaging synergistical imaging nanohybrids (Au~15~NCs-DTPAA-Gd). Compared with conventional multimodal nanoplatform usually requiring a complicated synthetic procedure, Au~15~NCs-DTPAA-Gd nanohybrids have the potential to overcome the limitations of interference between imaging elements. The nanohybrids are highly water-dispersible, biocompatible and stable, which can not only realize CT/MRI collaborative imaging, but also exhibit photoluminescent capability in NIR region. Under the condition of meeting the needs of diagnosis, the Au~15~NCs-DTPAA-Gd with a lower dose than traditional contrast agents can reduce the toxicity of contrast agents as much as possible. Overall, the developed Au~15~NCs-DTPAA-Gd nanoplatform provides an efficient candidate as an imaging contrast agent for disease diagnosis, especially for early accurate detection of tumors.
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